Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€350.97
Performance (%)
0.31%
Price
22:25
€280.85
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Amgen Inc. is nearly unchanged. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 2.692% | 2.692% |
| iShares Core DAX® | -0.471% | 0.925% |
| iShares Nasdaq 100 | 4.192% | 15.863% |
| iShares Nikkei 225® | -0.073% | 8.098% |
| iShares S&P 500 | 2.680% | 8.747% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $403.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat

